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Abstract
OBJECTIVES: This study evaluates whether a low preoperative quality of life (QoL), measured with the EuroQoL instruments EQ-5D and
EQ-visual analogue scale (VAS) can be used as a predictor of mortality after elective isolated myocardial revascularization.
METHODS: A total of 2501 patients, with a mean age of 65.3 ± 9.4 (range 18–93) years and a mean additive EuroSCORE of 2.7 ± 2.1 (0–12),
undergoing an elective isolated coronary artery bypass graft between January 2002 and June 2011 completed preoperative EQ-5D and EQ-VAS.
RESULTS: Hospital mortality [1.0% (25/2501 patients)] and 30-day mortality [1.2% (29/25 patients)] were the studied outcomes. The
EQ-5D was 0.69 ± 0.26 (−0.30 to 1.0) with a median of 0.77 and the EQ-VAS was 59.7 ± 22.4 (0–100) with a median of 60. Regression analysis
showed a signiﬁcant correlation between hospital mortality and EQ-5D (P = 0.016) and EQ-VAS (P = 0.033). There is a signiﬁcant correlation
between 30-day mortality and EQ-5D (P = 0.048), but not for EQ-VAS (P = 0.06). The c-statistics (95% conﬁdence interval) for EQ-5D and EQ-
VAS for predicting hospital mortality are 0.36 (0.24–0.46) and 0.33 (0.23–0.42), respectively. The c-statistics for predicting 30-day mortality are
0.39 (0.30–0.49) for EQ-5D and 0.35 (0.26–0.44) for EQ-VAS.
CONCLUSIONS: Based on these results, we conclude that, in isolation, poor low preoperative EQ-5D and EQ-VAS scores do not contribute to
deciding which patients should undergo cardiac surgery.
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INTRODUCTION
A patient’s mortality risk from a procedure is an important param-
eter in making a clinical decision on whether to go through with
the procedure or not. It is known that there is a correlation
between preoperative quality of life (QoL) and post-surgical recov-
ery in patients undergoing cardiac surgery [1–3]. Some research
has shown that preoperative QoL, or an aspect of the QoL, can be
used as an independent risk factor to predict post-surgical mortal-
ity and morbidity, certainly because the correlation between
preoperative anginal class and preoperative QoL is low [4–7].
These results raise the question whether a cardiac surgical proced-
ure can be denied for patients with a low preoperative QoL.
The aim of the present study is to evaluate whether pre-
operative QoL, using the EuroQoL [8], can be used to predict the
risk of mortality for patients undergoing isolated elective coron-
ary artery bypass graft (CABG) surgery.
PATIENTS AND METHODS
Patients
From our Coronary Surgery Database Radboud Hospital
(CORRAD)—a database that stores pre-, peri- and postoperative
data plus follow-up data from all adult patients undergoing
cardiac surgery at the Radboud University Nijmegen Medical
Centre (UMCN)—we identiﬁed 4107 patients who underwent
isolated CABG between January 2002 and June 2011. Of the 4107,
3330 surgeries were elective and 2501 of these patients completed
our preoperative EuroQoL-questionnaire on the day before
surgery. The initial EuroSCORE [9] was used for risk stratiﬁcation.
Follow-up
Patients who were discharged alive from the UMCN were seen
at the postoperative outpatient clinic 6 weeks after discharge.
Patients who did not show up were contacted by one of the
authors (L.N.) to complete their 30-day survival data.
Quality of life
To assess the QoL, the EQ-5D and EQ-VAS, both components of
the EuroQoL instrument, were used [8]. The EQ-5D consists of
ﬁve domains of health (mobility, self-care, usual activities, pain/
discomfort and anxiety/depression), and each domain is divided
into three levels: (i) no problems, (ii) some or moderate pro-
blems and (iii) extreme problems. Based on the response to this
© The Author 2012. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
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classiﬁcation, a single index value is estimated using a general
population-based algorithm [10]. Secondly, patients estimated
their own health on a visual analogue scale (EQ-VAS) ranging
from 0 to 100, with 0 being the worst possible health state and
100 being the best possible health state. The EQ-5D index can
be regarded as a societal-based composite global QoL measure,
whereas the EQ-VAS is a direct global QoL assessment from the
patient’s perspective.
All patients participated on a voluntary basis in this QoL re-
search. Registration of data in the CORRAD database and the use
of this information for research have been approved by the local
ethical and research council of the Radboud University,
Nijmegen [11].
Outcome variables
Study endpoints are hospital mortality, deﬁned as death occur-
ring at any time during hospital admission after CABG surgery,
and 30-day mortality, deﬁned as all hospital mortalities and all
deaths within 30 days postoperation in the group of patients
who were discharged from the UMCN before the 30th post-
surgical day.
Statistical analyses
Statistical analyses were performed using 16.0 SPSS Inc., Chicago,
IL, USA. Baseline characteristics are presented as a percentage
for dichotomous variables, as mean ± SD, and as a range for nu-
merical variables. Results from the EQ-5D and EQ-VAS are
completed with a median and the 25th and 75th percentiles
interquartile range (IQR range). Differences in percentages were
tested using the χ2 test and numerical variables were tested
using the t-test or Mann–Whitney test when appropriate. The as-
sociation between the EQ-5D, EQ-VAS and hospital or 30-day
mortality is evaluated using logistic regression analysis. The
Nagelkerke R2 (0–100%) was used to evaluate the association
between the EQ-5D and EQ-VAS. Receiver operator characteristic
curves (ROC curves) were used to assess the value of EQ-5D and
EQ-VAS as a predictor of hospitalisation or 30-day mortality.
Only patients with complete data from all pre- and post-
operative questionnaires were included in the analyses. A
P-value of ≤0.05 was considered signiﬁcant.
RESULTS
Patients
Between January 2002 and June 2011, 4107 isolated myocardial
revascularizations were performed at the UMCN, with a hospital
mortality of 70 patients (1.7%). After excluding urgent and emer-
gency surgery, plus patients with a recent myocardial infarction
as deﬁned by the EuroSCORE [9], we identiﬁed 3330 patients
who underwent isolated elective CABG (total population). Of
these patients, 2501 (75%) had complete QoL data, our study
population, 829 patients without or with incomplete QoL data
were excluded, the exclusion group.
Table 1 presents the baseline characteristics of the total group,
the study population and the exclusion group. Diabetes is
deﬁned as diet-controlled, oral therapy or insulin-dependent
Table 1: Baseline characteristics of patients
Variable Total group [n = 3330 (%)] Study population [n = 2501 (%)] Excluded group [n = 829 (%)] P-value*
Age (years) 65.5 ± 9.7 (18–93) 65.3 ± 9.4 (18–93) 66.4 ± 10.2 (35–91) 0.011
Female 753 (22.6) 525 (21.0) 228 (27.8) 0.001
Diabetes 735 (22.1) 542(21.7) 193 (23.1) 0.333
Vascular disease 525 (15.8) 391 (15.6 134 (16.3) 0.717
Neurological disease 298 (8.9) 226 (9.0) 72 (8.7) 0.759
Renal disease 92 (2.8) 68 (2.7) 24 (2.9) 0.789
Pulmonary disease 380 (11.4) 281 (11.2) 99 (11.9) 0.579
Preoperative myocardial infarction 1101 (33.1) 836 (33.4) 265 (32.0) 0.439
Previous cardiac surgery 116 (3.5) 86 (3.4) 30 (3.6) 0.823
Body mass index (kg/m2) 27.4 ± 4.0 (17.5–48.2) 27.5 ± 4.1 (17.5–48.2) 27.1 ± 4.1 (17.5–47.6) 0.555
Additive EuroSCORE 2.8 ± 2.2 (0–12) 2.7 ± 2.1 (0–12) 3.1 ± 2.3 (0–12) 0.001
Groups 0.002
Low risk 1545 (46.4) 1197 (47.9) 348 (42.0)
Medium risk 1353 (40.6) 1003 (40.1) 350 (42.2)
High risk 432 (13.0) 301 (9.0) 131 (15.8)
Three-vessel disease 2465 (74) 1859 (74.3) 606 (73.1) 0.747
Extracorporeal circulation (min) 100 ± 31 (11–359) 100 ± 31.8 (11–310) 99 ± 33.2 (27–359) 0.965
Aortic cross-clamp time (min) 59 ± 20 (6–187) 60 ± 21.8 (7–187) 59.6 ± 22.8 (6–166) 0.886
Off pump 235 (7.1) 181 (7.2) 54 (6.4) 0.481
Grafts (number) 1.9 ± 0.4 (1–4) 1.9 ± 0.44 (1–4) 1.9 ± 0.46 (1–4) 0.348
Distal anastomoses (number) 3.7 ± 1.2 (1–9) 3.6 ± 1.2 (1–9) 3.7 ± 1.2 (1–8) 0.186
EQ-5D 0.69 ± 0.26 (−0.30 to 1.0); 0.77 IQR: 0.65–0.84
EQ-VAS 59.7 ± 22.4 (−0 to 100); 60 IQR:50–75
Hospital mortality 36 (1.1) 25 (1.0) 11 (1.3) 0.430
30-day mortality 41 (1.2) 29 (1.2) 12 (1.4) 0.515
*P-value study population versus exclusion group.
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diabetes; vascular disease as peripheral, abdominal vascular
pathology or operation; and neurological disease as cerebrovas-
cular accidents and/or transient ischaemic attack. Patients with a
preoperative creatinine ≥150 µmol/l, preoperative dialysis or a
renal transplant were registered under renal disease, and for pul-
monary diseases the same deﬁnition has been used as applied
by the EuroSCORE [9].
The study population has a mean age of 65.3 ± 9.4 (range
18–93) years. The EQ-5D is 0.69 ± 0.26 (−0.30 to 1.0), median of
0.77 (IQR 0.65–0.84) and the EQ-VAS is 59.7 ± 22.4 (0–100),
median of 60 (IQR 50–75). The mean additive EuroSCORE is
2.7 ± 2.1 (0–12). Hospital mortality was 1.0% (25/2501 patients)
and 30-day mortality was 1.2% (29/25). Statistical analysis shows
that the exclusion group is signiﬁcantly older (P = 0.0110),
consists of more women, 27.8 versus 21% (P = 0.001), has a
signiﬁcantly higher percentage of high-risk patients, 15.8 versus
9% (P = 0.002), and has a signiﬁcantly higher additive EuroSCORE
risk score, 3.1 ± 2.3 (0–12) versus 2.7 ± 2.1 (0–12) (P = 0.001). Other
studied variables show no statistically signiﬁcant difference.
QoL and mortality
Table 2 presents the values of EQ-5D, EQ-VAS, the additive
EuroSCORE and the age of hospital survivors versus hospital
deaths for both 30-day survivors and 30-day deaths. Patients
who died either during hospital admission or within 30-day
post-surgery were signiﬁcantly older than survivors (P = 0.001). In
addition, the additive EuroSCORE is signiﬁcantly higher for
patients who died (P = 0.001), whereas the value of the EQ-5D is
lower in the group of hospital deaths (P = 0.048). The EQ-VAS is
signiﬁcantly lower for both hospital and 30-day deaths (P = 0.011
and P = 0.021, respectively).
The association between the EQ-5D, EQ-VAS and hospital
mortality is signiﬁcant but very low; EQ-5D (P = 0.016; R2 =
0.020), EQ-VAS (P = 0.033; R2 = 0.016). The association between
EQ-5D and EQ-VAS and 30-day mortality is signiﬁcant for EQ-5D
(P = 0.048; R2 = 0.012), but not for EQ-VAS (P = 0.06; R2 = 0.011).
Both associations have a low correlation.
The c-index (95% conﬁdence interval) for EQ-5D, EQ-VAS and
the additive EuroSCORE for predicting hospital mortality are 0.36
(0.24–0.46), 0.33 (0.23–0.42) and 0.80 (0.71–0.87), respectively
(Fig. 1). The c-index for predicting 30-day mortality is 0.39 (0.30–
0.49) for EQ-5D and 0.35 (0.26–0.44) for EQ-VAS.
DISCUSSION
Several research groups have focused on various QoL assess-
ments to test the predictive value for short- and long-term mor-
tality of patients undergoing cardiac surgery [1–7]. In the present
study, we took a closer look at the predictive value of EQ-5D
and EQ-VAS, both components of the EuroQoL facility [8]. In our
study population, only isolated elective CABG patients were
included. Patients with urgent and emergency surgeries were
excluded from our analyses as the medical indication for cardiac
surgery in these cases is strictly regulated. Patients with a recent
myocardial infarction, as deﬁned by the EuroSCORE [9], were
excluded. For some of these patients, the medical indication was
decisive to perform a CABG and it was impossible to distinguish
these speciﬁc patients in our database. From the 3330 patients
(total population) who could be included in our study, 2501
(75%) had complete QoL data. The remaining 829 patients (25%)
were excluded as their QoL data were incomplete. The issue of
incomplete QoL data is a known problem in this kind of research
[11]. It is important to notice that the exclusion group is signiﬁ-
cantly older, has a higher percentage of women and has a
higher risk score preoperatively. Table 1 shows that besides age
and gender, other risk variables show no signiﬁcant difference. It
Table 2: Age, additive EuroSCORE, EQ-5D and EQ-VAS of hospital deaths versus hospital survivors
Variable Survivors (n = 2476) Hospital deaths (n = 25) P-value
Age 65.3 ± 9.4 72.3 ± 7.9 0.001
EuroSCORE 2.7 ± 2.1 5.2 ± 2.7 0.001
EQ-5D 0.70 ± 0.26 (−0.30 to 1); 0.77 IQR 0.65–0.84 0.57 ± 0.31 (−27 to 0.89); 0.68 IQR 0.25–0.80 0.048
EQ-VAS 59.8 ± 22.5 (0–100); 60 IQR 50–75 50.1 ± 17.4 (20–95); 50 (IQR 39–60) 0.011
Survivors (n = 2472) 30-day deaths (n = 29)
Age 65.3 ± 9.4 72.3 ± 7.9 0.001
EuroSCORE 2.7 ± 2.1 5.2 ± 2.7 0.001
EQ-5D 0.70 ± 0.26 (−30 to 10); 0.77 IQR 0.65–0.84 0.60 ± 0.31 (−27 to 0.89); 0.69 IQR 40–82 0.090
EQ-VAS 59.8 ± 22.5 (0–100); 60 (50–75) 51.1 ± 17.4 (20–95); 50 (40–61) 0.021
Figure 1: ROC curve for EQ-5D (full line), EQ-VAS (dotted line) and additive
EuroSCORE (dashed line) for hospital mortality.
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is important to notice that the operative data and the registered
hospital and 30-day mortality show no differences between the
study population and the exclusion group.
Table 2 shows that hospital and 30-day mortality appear, as
expected, in patients who are signiﬁcantly older and at a higher
risk than survivors. The EQ-5D is close to a statistically signiﬁcant
level (P = 0.048). The EQ-5D is lower for hospital deaths but
shows no signiﬁcant difference between 30-day deaths and
survivors. The EQ-VAS is signiﬁcantly lower for both hospital and
30-day deaths. Logistic regression analysis shows a signiﬁcant
correlation between hospital mortality and EQ-5D and EQ-VAS,
as well as between 30-day mortality and EQ-5D, albeit with a
poor association. (Nagelkerke R2 < 0.021 for all correlations).
The c-index for the predictive value of EQ-5D and EQ-VAS for
hospital mortality are 0.36 and 0.33, respectively. The c-index for
the predictive value of EQ-5D and EQ-VAS for 30-day mortality
are 0.39 and 0.35, respectively. These results show that both
EQ-5D and EQ-VAS have no prognostic value for hospital or
30-day mortality. The c-index of the additive EuroSCORE for
hospital and 30-day mortality (0.80 for both mortality measure-
ments), however, conﬁrms that the additive EuroSCORE is a
good prognostic tool to predict the mortality rate of patients
undergoing isolated elective CABG surgery.
Our results—no prognostic value of QoL, evaluated by the
EuroQoL facility, for hospital and 30-day mortality—seem to be
in contrast with previous published researches [4–6]. Rumsfeld
et al. [4] proved that the preoperative physical component
summary (PCS) score is an important independent risk factor for
6-month mortality following CABG surgery [4]. However, emer-
gency and acute operations are included in his study population,
and the baseline characteristics of the study population differed
greatly from the exclusion group. About 37% of the patients
(1476/3956) were excluded in the study, which is much higher
than in our research. Another point is that we present a series of
2501 patients operated over a period of 9 and a half years, with
a hospital mortality of 25 patients (1%) and a 30-day mortality of
29 patients (1.2%). This is in contrast with Rumsfeld et al. [4] who
present a series of 2480 patients with a 180-day mortality of 117
patients (4.7%). So, it can be suggested that our number of
deaths (endpoints) is too small. However, if elective isolated
CABG can be performed with a hospital, 30-day mortality <1.5%,
the inﬂuence of QoL on this mortality is of course much less.
Sündermann et al. [5] use the comprehensive assessment of
frailty (CAF) to analyse the ability to predict one-year mortality.
For their analyses they used a highly speciﬁc group of patients,
only those with an age of ≥74 years. This is an important differ-
ence in our study, mainly because some studies conﬁrm the in-
ﬂuence of age on the QoL [12, 13]. QoL is measured using the
CAF test, which is a new facility speciﬁcally for older patients [5].
Their results show a promising ability to predict one-year mor-
tality, even much better than the EuroSCORE. Székely et al. used
both PCS and MCS of the SF-12 to predict a prolonged length of
in-hospital stay and mortality [6]. The MCS is identiﬁed as an
independent predictor of a prolonged length of hospital stay
and mortality. However, the data set used for their research is
almost 10 years old and was gathered together from a total of
72 hospitals in 17 different countries. In addition, they give no
additional information about the exclusion criteria used. The
problem of missing QoL data and information about the
excluded patients is mentioned earlier in the discussion and is
not a new phenomenon [14]. In our research, we excluded
patients with no or incomplete QoL data. It is interesting to see
that the exclusion group is older and at a higher risk for mortal-
ity, and this must be taken into account before generalizing the
results.
CONCLUSION
In conclusion, our results support the hypothesis that in isolation,
poor preoperative QoL, measured using EQ-5D and EQ-VAS,
cannot contribute in deciding which patients should undergo
isolated elective CABG surgery.
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